Patients with gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for Adverse Events (CTCAE) grade >=  within  days prior to study entry
Has known gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for Adverse Events (CTCAE) grade >  within  months of start of study drug
Any hemorrhage or bleeding event >= National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) grade  within  weeks prior to start of study medication
Has gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for Adverse Events (CTCAE) grade >  within  months of registration
Pulmonary hemorrhage/bleeding event > Common Terminology Criteria for Adverse Events (CTCAE) grade  within  weeks of first dose of study drug
Contraindication to antiangiogenic agents, including:\r\n* Bronchopulmonary hemorrhage/bleeding event >= grade  (Common Terminology Criteria for Adverse Events [CTCAE] v.) within  weeks prior to of initiation of treatment\r\n* Any other hemorrhage/bleeding event >= grade  (CTCAE v.) within  weeks prior to initiation of treatment\r\n* Serious non-healing wound, ulcer, or bone fracture
Patients with gastrointestinal bleeding or any other hemorrhage/bleeding event (Common Terminology Criteria for Adverse Events [CTCAE] version [v.]) grade  or greater within  days prior to registration will be ineligible
Pulmonary hemorrhage/bleeding event >= Common Terminology Criteria for Adverse Events (CTCAE) grade  within  weeks of first dose of study drug
Subjects who have a history or current evidence of bleeding disorder, i.e. any hemorrhage/bleeding event of Common Terminology Criteria for Adverse Events (CTCAE) grade >=  within  weeks before the start of study treatment
Has history of gastrointestinal bleeding or any other hemorrhage/bleeding event >= grade  (Common Terminology Criteria for Adverse Events [CTCAE], version [v.] ) within  days prior to entry in to the trial
Subjects who have a history or current evidence of bleeding disorder, i.e. any hemorrhage / bleeding event of CTCAE (Common Terminology Criteria for Adverse Events) Grade ? within  weeks before the start of study Treatment.
Has gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for Adverse Events (CTCAE) grade >  within  months of start of study drug
Any hemorrhage or bleeding event >= National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) version  grade  =<  weeks prior to registration
Gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for adverse Events (CTCAE), v.  grade  or greater within  days prior to registration
Patients with evidence or history of bleeding diathesis. Any hemorrhage or bleeding event ? CTCAE Grade  within  weeks of start of study medication (CTCAE: Common Terminology Criteria for Adverse Events).
Patients with gastrointestinal bleeding or any other hemorrhage/bleeding event Common Terminology Criteria for Adverse Events (CTCAE) grade >=  within  days prior to study entry
Evidence or history of bleeding diathesis. Any hemorrhage/bleeding event ? CTCAE (Common terminology criteria for adverse events) Grade  within  weeks of first dose of study drug
Any hemorrhage or bleeding event >= National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version (v). grade  within  weeks prior to start of study medication
Has gastrointestinal bleeding or any other hemorrhage/bleeding event National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) >Grade  within  months of start of study drug.
Pulmonary hemorrhage/bleeding event > National Cancer Institute Common Terminology Criteria for Adverse Events (NCI-CTCAE, version .) grade  within  weeks of enrollment
Pulmonary hemorrhage/bleeding event >= Common Terminology Criteria for Adverse Events (CTCAE) grade  within  weeks of first dose of study drug
Pulmonary hemorrhage/bleeding event >= Common Terminology Criteria for Adverse Events (CTCAE) Grade  within  weeks of first dose of study drug
Any hemorrhage or bleeding event >= Common Terminology Criteria for Adverse Events (CTCAE) grade  within  weeks prior to start of study medication
